NCBiotech News

Enhancing soil health is “One of those rare win-win situations,” Wayne Honeycutt, president and CEO of the Morrisville, NC-based Soil Health Institute told the 2018 Ag Biotech Summit. “It’s good for the farmer and for the environment.”

Many of us chose a career in the life sciences to make a difference. To cure diseases. To improve the environment. To feed the world. But it’s easy to lose the big picture as we focus on the details of our daily routine.

North Carolina is one of five states consistently recognized for its specialized life science industry. The state’s strong network of life science companies, universities and skilled workforce provide a strong advantage for companies of all sizes and stages of development. Statewide, North Carolina has more than 700 life science companies with 63,000 employees, and employment within life sciences is growing at 6.6 percent – triple the national average.

Scientists, executives and farmers at the 2018 Ag Biotech Summit focused on soil health agreed on its importance to plant, animal and human health.

Bioventus, a global orthobiologics company based in Durham, has launched Durolane, its single-injection, hyaluronic acid (HA) joint lubricant for treating knee osteoarthritis pain, following FDA approval last summer.

G1 Therapeutics, a clinical-stage oncology company based in Research Triangle Park, has reported positive top-line data from a Phase 2a trial of trilaciclib, its potential therapy for patients who are taking chemotherapy for small-cell lung cancer.

The global diabetes and obesity epidemic is driving an additional $65 million expansion of Novo Nordisk’s drug-manufacturing operations at its 264-acre campus in Clayton.

Five “alumni” companies of the Council for Entrepreneurial Development reported major progress at the CED’s Life Sciences Conference in Raleigh.

North Carolina, rich in scientific expertise and supporting resources, is one of the nation’s best places to start a life science enterprise, a panel of early stage company entrepreneurs agreed at the CED Life Science Conference in Raleigh.

Scientists at North Carolina State University’s Plants for Human Health Institute have received $2 million to support research aimed at improving the nutritional content of food products containing fruits and vegetables.

Rx Maker, a Durham spinoff from Ag TechInventures, is commercializing a technology to help farmers use high-resolution satellite imagery to pinpoint their soil issues.

Greensboro-based Kepley BioSystems (KBI), developer of a reusable, synthetic bait for the lobster and crab fisheries and other marine technologies, is one of only 11 U.S. companies invited to America’s Small Business Development Center (SBDC) Client Showcase in Washington, D.C., on Feb. 13.

Raleigh-based Innovate Biopharmaceuticals, a clinical stage biotechnology company focused on developing novel autoimmune and inflammation therapeutics, has completed its reverse merger with California-based Monster Digital and is now a publicly traded company.

Clinical data company TARGET PharmaSolutions of Chapel Hill has expanded its stable of major pharmaceutical company strategic alliances by adding Novartis to its study of liver disease.

Galaxy Diagnostics is confronting a mysterious health menace with a growing suite of commercial tests for accurately detecting Bartonella and other pathogens in people and animals.